Sara Becerril
Overview
Explore the profile of Sara Becerril including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
1790
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Catalan V, Gomez-Ambrosi J, Ramirez B, Unamuno X, Becerril S, Rodriguez A, et al.
Mol Med
. 2024 Dec;
30(1):255.
PMID: 39707172
Background: PIEZO1 has emerged as a mechanoreceptor linked with adipogenesis, adipose tissue (AT) inflammation and insulin resistance. We aimed to determine the impact of obesity and obesity-associated type 2 diabetes...
2.
Neira G, Hernandez-Pardos A, Becerril S, Ramirez B, Valenti V, Moncada R, et al.
Obesity (Silver Spring)
. 2024 Sep;
32(11):2120-2134.
PMID: 39327772
Objective: Fibronectin type III domain-containing protein 5 (FNDC5) modulates adipocyte metabolism by increasing white and brown adipose tissue (WAT and BAT) browning and activity, respectively. We investigated whether FNDC5 can...
3.
Neira G, Gomez-Ambrosi J, Cienfuegos J, Ramirez B, Becerril S, Rodriguez A, et al.
J Physiol Biochem
. 2024 Sep;
PMID: 39305371
Excess adiposity contributes to the development of colon carcinoma (CC). Interleukin (IL)-1β is a pro-inflammatory cytokine relevant in obesity-associated chronic inflammation and tumorigenic processes. We herein aimed to study how...
4.
Neira G, Becerril S, Valenti V, Moncada R, Catalan V, Gomez-Ambrosi J, et al.
Clin Nutr
. 2024 Aug;
43(9):2221-2233.
PMID: 39173437
Background: The molecular mediators responsible for the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) to steatohepatitis (MASH) have not yet been completely disentangled. We sought to analyze whether FNDC4,...
5.
Gomez-Ambrosi J, Catalan V, Ramirez B, Salmon-Gomez L, Marugan-Pinos R, Rodriguez A, et al.
Eur J Intern Med
. 2024 Mar;
124:54-60.
PMID: 38453570
Background: The estimation of obesity-associated cardiometabolic risk does not usually take into account body composition or the distribution of adiposity. The aim of the present study was to assess the...
6.
Fruhbeck G, Gomez-Ambrosi J, Ramirez B, Becerril S, Rodriguez A, Mentxaka A, et al.
Cell Mol Life Sci
. 2024 Feb;
81(1):77.
PMID: 38315242
Background: Obesity-associated dysfunctional intestinal permeability contributes to systemic chronic inflammation leading to the development of metabolic diseases. The inflammasomes constitute essential components in the regulation of intestinal homeostasis. We aimed...
7.
Becerril S, Cienfuegos J, Rodriguez A, Catalan V, Ramirez B, Valenti V, et al.
J Physiol Biochem
. 2023 Nov;
80(1):149-160.
PMID: 37935948
Bariatric surgery has become a recognized and effective procedure for treating obesity and type 2 diabetes (T2D). Our objective was to directly compare the caloric intake-independent effects of sleeve gastrectomy...
8.
Oliveras-Canellas N, Moreno-Navarrete J, Lorenzo P, Garrido-Sanchez L, Becerril S, Rangel O, et al.
J Clin Endocrinol Metab
. 2023 Aug;
109(1):e145-e154.
PMID: 37560997
Context: Climate change and global warming have been hypothesized to influence the increased prevalence of obesity worldwide. However, the evidence is scarce. Objective: We aimed to investigate how outside temperature...
9.
Fernandez-Saez E, Losarcos M, Becerril S, Valenti V, Moncada R, Martin M, et al.
Metabolism
. 2023 Jul;
147:155663.
PMID: 37517791
Background: The biological mediators supporting the resolution of liver steatosis, inflammation and fibrosis after bariatric surgery in patients with obesity and NAFLD remain unclear. We sought to analyze whether uroguanylin...
10.
Ezquerro S, Tuero C, Becerril S, Valenti V, Moncada R, Landecho M, et al.
Eur J Endocrinol
. 2023 Jun;
188(7):564-577.
PMID: 37358209
Background: Growing evidence suggests the key role of ghrelin in the onset and progression of nonalcoholic fatty liver disease (NAFLD). The potential participation of ghrelin and the ghrelin receptor antagonist,...